LivaNova PLC

LIVN Healthcare Medical Devices

LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024.

Revenue
+9.88%
EPS
+27.4%
Free cash flow
−31.0%
Total debt
−31.2%

Quarter to September 2026, against a year earlier

90.21 0.93 −1.02%
Market cap
$5.0B
P/E
25.6×
Fwd P/E
19.8×
Dividend yield
—
F-score
4/9
Altman Z
1.74
Beneish M
−3.30
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — 4 4 2 6 6 5 7 4
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 157.94 39.92 0.00
Altman Z-Score
2.76 4.09 2.54 2.13 1.26 2.82 1.68 1.60 1.79 1.74
P/S ratio
2.30 3.80 4.01 3.36 3.44 4.28 2.89 2.36 2.00 2.42
Altman Z″-Score (non-manufacturers)
4.19 4.19 0.63 0.49 0.19 0.11 1.23 1.44 2.26 0.72
P/FCF ratio
48.29 65.95 46.43 0.00 0.00 60.06 73.68 72.24 18.93 18.94
P/Operating CF
54.27 217.84 212.35 1,272.49 86.99 132.22 157.79 50.52 31.91 40.73
Beneish M-Score
— (2.32) (3.12) (2.77) (3.36) (2.93) (2.95) (2.35) (2.82) (3.30)
P/B ratio
1.30 2.12 2.95 2.64 2.90 3.42 2.44 2.13 1.90 2.80
EV/Sales
2.38 3.86 4.12 3.62 3.87 4.31 2.91 2.37 1.93 2.23
EV/EBITDA
14.09 18.48 0.00 0.00 0.00 53.16 22.59 239.67 11.97 10.98
EV/FCF
50.10 66.85 47.70 (32.92) (30.73) 60.48 74.33 72.48 18.21 17.48
Current Ratio
2.32 2.14 1.07 1.07 2.29 0.97 2.98 2.95 2.87 1.36
Net Debt/EBITDA
0.51 0.25 (0.74) (6.29) (2.49) 0.38 0.20 0.77 (0.48) (0.92)
Debt/Equity
0.07 0.08 0.11 0.24 0.59 0.19 0.45 0.46 0.48 0.31
ROE
(3.57%) (1.42%) (11.41%) (10.92%) (27.98%) (11.30%) (6.89%) 1.41% 4.87% (19.24%)
ROA
(2.56%) (1.04%) (7.50%) (6.35%) (14.50%) (5.90%) (3.84%) 0.74% 2.56% (9.49%)
ROIC
1.17% 3.23% (9.54%) (6.46%) (11.32%) (0.04%) (3.89%) (3.33%) 6.59% 13.24%
Return on Tangible Assets
(9.42%) (3.82%) (83.09%) (72.23%) (61.98%) (102.68%) (11.72%) 2.17% 6.98% (45.22%)
Average Days of Receivables
80.67 101.73 84.46 86.78 72.03 65.34 65.41 68.05 56.25 56.80
Earnings Yield
(2.85%) (0.65%) (4.27%) (4.26%) (10.69%) (3.04%) (2.92%) 0.63% 2.50% (7.23%)
Free Cash Flow Yield
2.07% 1.52% 2.15% (3.27%) (3.66%) 1.67% 1.36% 1.38% 5.28% 5.28%
Free Cash Flow per Share
1.08 1.31 1.99 (2.46) (2.36) 1.52 0.81 0.76 2.51 3.31
Book value per Share
34.93 37.70 31.01 28.62 22.83 25.57 22.58 23.69 24.34 22.00
Free Cash Flow
52.93 63.17 96.71 (119.12) (114.45) 77.07 43.40 41.09 136.02 180.57
EV/EBIT
68.69 40.45 0.00 0.00 0.00 0.00 0.00 0.00 18.72 15.53
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026